Lars Henrick Peeck

Astraveus SAS is a French-based company founded in 2016 by Jérémie Laurent. The company is based in Paris, France and is supported by adbio partners, m ventures, Johnson & Johnson Innovation – JJDC Inc, and Bpifrance Large Venture. The company is developing the next generation of cell and gene therapy manufacturing solutions. The company's cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. The platform enables greater precision and easier replication of optimal manufacturing, delivering better therapies in a more cost- and time-efficient manner, using fewer materials and with reduced environmental impact. This transformative solution has the potential to enable a therapeutic revolution at scale, helping to make these lifesaving therapies accessible to the many thousands of patients around the world that need them. Astraveus is a member of the #FrenchTech2030 program by La French Tech, granting support from high rank French institutions like the Secrétariat Général pour l'Investissement, Bpifrance, and, for healthcare companies, of the Agence de l'Innovation en Santé. Jérémie Laurent has been the CEO since 2016.

Merck Life Science GmbH manufactures and markets microbial diagnostics, monitoring and sterility testing cultures and solutions. The company is headquartered in Eppelheim, Germany.

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.